BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38781869)

  • 1. Monastrol suppresses invasion and metastasis in human colorectal cancer cells by targeting fascin independent of kinesin-Eg5 pathway.
    Alburquerque-González B; Montoro-García S; Bernabé-García Á; Bernabé-García M; Campioni-Rodrigues P; Rodríguez-Martínez A; Luque I; Salo T; Pérez-Garrido A; Pérez-Sánchez H; Cayuela ML; Luengo-Gil G; Luchinat E; Postigo-Corrales F; Staderini T; Nicolás FJ; Conesa-Zamora P
    Biomed Pharmacother; 2024 Jun; 175():116785. PubMed ID: 38781869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel anti-invasive properties of a Fascin1 inhibitor on colorectal cancer cells.
    Montoro-García S; Alburquerque-González B; Bernabé-García Á; Bernabé-García M; Rodrigues PC; den-Haan H; Luque I; Nicolás FJ; Pérez-Sánchez H; Cayuela ML; Salo T; Conesa-Zamora P
    J Mol Med (Berl); 2020 Mar; 98(3):383-394. PubMed ID: 31996952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 controls colorectal cancer cell invasion by inhibiting the NF-κB-mediated activation of Fascin.
    Sui X; Zhu J; Tang H; Wang C; Zhou J; Han W; Wang X; Fang Y; Xu Y; Li D; Chen R; Ma J; Jing Z; Gu X; Pan H; He C
    Oncotarget; 2015 Sep; 6(26):22869-79. PubMed ID: 26362504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migrastatin analogues target fascin to block tumour metastasis.
    Chen L; Yang S; Jakoncic J; Zhang JJ; Huang XY
    Nature; 2010 Apr; 464(7291):1062-6. PubMed ID: 20393565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional expression of fascin increases tumor progression in a mouse model of intestinal cancer.
    Schoumacher M; El-Marjou F; Laé M; Kambou N; Louvard D; Robine S; Vignjevic DM
    Eur J Cell Biol; 2014 Oct; 93(10-12):388-95. PubMed ID: 25269996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis and Molecular Docking Studies of Some Tetrahydropyrimidine Derivatives as Possible Fascin Inhibitors.
    Riahi N; Kefayat A; Ghasemi A; Asgarshamsi M; Panjehpoor M; Fassihi A
    Chem Biodivers; 2019 Feb; 16(2):e1800339. PubMed ID: 30284762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein.
    Peters T; Lindenmaier H; Haefeli WE; Weiss J
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):291-9. PubMed ID: 16365780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual actin-bundling and protein kinase C-binding activities of fascin regulate carcinoma cell migration downstream of Rac and contribute to metastasis.
    Hashimoto Y; Parsons M; Adams JC
    Mol Biol Cell; 2007 Nov; 18(11):4591-602. PubMed ID: 17855511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving fascin inhibitors to block tumor cell migration and metastasis.
    Han S; Huang J; Liu B; Xing B; Bordeleau F; Reinhart-King CA; Li W; Zhang JJ; Huang XY
    Mol Oncol; 2016 Aug; 10(7):966-80. PubMed ID: 27071719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro.
    Jawhari AU; Buda A; Jenkins M; Shehzad K; Sarraf C; Noda M; Farthing MJ; Pignatelli M; Adams JC
    Am J Pathol; 2003 Jan; 162(1):69-80. PubMed ID: 12507891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
    Müller C; Gross D; Sarli V; Gartner M; Giannis A; Bernhardt G; Buschauer A
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):157-64. PubMed ID: 16703323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fascin-1 as a biomarker and prospective therapeutic target in colorectal cancer.
    Adams JC
    Expert Rev Mol Diagn; 2015 Jan; 15(1):41-8. PubMed ID: 25370828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cell-based fascin bioassay identifies compounds with potential anti-metastasis or cognition-enhancing functions.
    Kraft R; Kahn A; Medina-Franco JL; Orlowski ML; Baynes C; López-Vallejo F; Barnard K; Maggiora GM; Restifo LL
    Dis Model Mech; 2013 Jan; 6(1):217-35. PubMed ID: 22917928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the human kinesin Eg5 that confer resistance to monastrol and S-trityl-L-cysteine in tumor derived cell lines.
    Tcherniuk S; van Lis R; Kozielski F; Skoufias DA
    Biochem Pharmacol; 2010 Mar; 79(6):864-72. PubMed ID: 19896928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5.
    DeBonis S; Simorre JP; Crevel I; Lebeau L; Skoufias DA; Blangy A; Ebel C; Gans P; Cross R; Hackney DD; Wade RH; Kozielski F
    Biochemistry; 2003 Jan; 42(2):338-49. PubMed ID: 12525161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The actin-bundling protein fascin stabilizes actin in invadopodia and potentiates protrusive invasion.
    Li A; Dawson JC; Forero-Vargas M; Spence HJ; Yu X; König I; Anderson K; Machesky LM
    Curr Biol; 2010 Feb; 20(4):339-45. PubMed ID: 20137952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA‑MTO1 suppresses breast cancer cell viability and reverses monastrol resistance through regulating the TRAF4/Eg5 axis.
    Liu Y; Dong Y; Zhao L; Su L; Luo J
    Int J Oncol; 2018 Oct; 53(4):1752-1762. PubMed ID: 30015883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells.
    Alburquerque-González B; Bernabé-García M; Montoro-García S; Bernabé-García Á; Rodrigues PC; Ruiz Sanz J; López-Calderón FF; Luque I; Nicolas FJ; Cayuela ML; Salo T; Pérez-Sánchez H; Conesa-Zamora P
    Exp Mol Med; 2020 Feb; 52(2):281-292. PubMed ID: 32080340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel Rho-dependent pathway that drives interaction of fascin-1 with p-Lin-11/Isl-1/Mec-3 kinase (LIMK) 1/2 to promote fascin-1/actin binding and filopodia stability.
    Jayo A; Parsons M; Adams JC
    BMC Biol; 2012 Aug; 10():72. PubMed ID: 22883572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes.
    Li A; Morton JP; Ma Y; Karim SA; Zhou Y; Faller WJ; Woodham EF; Morris HT; Stevenson RP; Juin A; Jamieson NB; MacKay CJ; Carter CR; Leung HY; Yamashiro S; Blyth K; Sansom OJ; Machesky LM
    Gastroenterology; 2014 May; 146(5):1386-96.e1-17. PubMed ID: 24462734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.